跳到主要导航 跳到搜索 跳到主要内容

Correction to: Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer (Naunyn-Schmiedeberg's Archives of Pharmacology, (2022), 395, 3, (315-324), 10.1007/s00210-022-02203-9)

  • He Jiang
  • , Guotai Wang
  • , Jingtao Gu
  • , Ying Xiao
  • , Pengli Wang
  • , Xin Huang
  • , Huanchen Sha
  • , Zheng Wang
  • , Qingyong Ma
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Shaanxi University of Chinese Medicine
  • Central Hospital of Xi'an

科研成果: 期刊稿件评论/辩论

摘要

The authors regret that Fig. 1 containing a pair of invasion photos, which is located in red frame of I position as below, should be replaced due to error. It came to attention after publication. The reason is that author mistakenly saved photos from lab’s shared computer in the final steps of data preparation. (Figure presented.) In order to meet high standard of Naunyn-Schmiedebergs Archives of Pharmacology and to be responsible for preciseness of study, I wish to perform a corrigendum of Fig. 1. The corrected Fig. 1 is provided below. This error did not impact the conclusions of the article. The authors apologize for this error. (Figure presented.).

源语言英语
页(从-至)1591-1593
页数3
期刊Naunyn-Schmiedeberg's Archives of Pharmacology
396
7
DOI
出版状态已出版 - 7月 2023
已对外发布

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Correction to: Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer (Naunyn-Schmiedeberg's Archives of Pharmacology, (2022), 395, 3, (315-324), 10.1007/s00210-022-02203-9)' 的科研主题。它们共同构成独一无二的学术指纹。

引用此